Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Kankakee-Bradley, IL MSA — September 2026
Kankakee CRA pay surges as local labor market stays volatile.
Clinical Research Associate advertised pay jumped to a $83,763 metro median against a volatile backdrop where Kankakee unemployment swung from 7.0% in February to 4.1% by July.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Kankakee unemployment rate: 4.1% — Down from 7.0% in Feb 2026, up from 5.5% Sept 2025
- Metro nonfarm payroll change: -2.1% — Year-over-year through Sept 2025, largest decline in IL
- CRA advertised pay, metro: $83,763 — vs $90,956 national median, up significant
- Illinois labor force change: -94,600 workers — Year-over-year through Aug 2026, tightens talent pipeline
Key takeaways
CRA pay is catching up to national levels fast.
Metro CRA advertised pay rose to a $83,763 median, a significant increase that closes much of the gap with the $90,956 national figure. This is consistent with tightening local clinical talent supply as biopharma employers compete against broader regional manufacturing hiring driven by the EV-battery facility buildout.
Validation Engineer pay gap may reflect muted local leverage, not lower demand.
Metro Validation Engineer pay sits $8,730 below the national median and has stayed stable while national pay rose moderately. Smaller local employer base likely limits bidding wars seen in larger biopharma hubs, but risks losing engineers to remote-eligible roles priced at national rates.
Kankakee's job losses complicate build-vs-outsource math.
Total nonfarm payrolls fell 2.1% year-over-year even as unemployment swung from 5.5% to 7.0% and back to 4.1% within months, signaling volatile labor supply rather than steady availability. Life sci leaders weighing in-house quality or manufacturing expansion should treat local hiring timelines as less predictable than state-level data implies.
Statewide biotech wage compression narrows the outsourcing calculus.
Illinois biotech compensation averages $76,680 against a $153,000 average across all life sciences roles statewide, a wide tier gap that makes senior scientist and quality retention economically rational for larger operations but cost-prohibitive for smaller Kankakee-area employers. This may push smaller biopharma sites toward CDMO/CRO partnerships for specialized functions rather than building internal depth.
Median advertised pay by role — Kankakee-Bradley, IL MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $96,319 | $155,478 | $180,500 | Significant increase | $131,354 |
| Clinical Research Associate * | $63,752 | $83,763 | $100,011 | Significant increase | $90,956 |
| Lab Technician * | $40,473 | $46,621 | $52,991 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $68,679 | $93,330 | $114,685 | Significant increase | $104,000 |
| Clinical Data Manager * | $97,834 | $121,911 | $121,911 | Stable | $123,031 |
| Biostatistician * | $94,961 | $130,897 | $152,459 | Stable | $133,322 |
| Validation Engineer * | $85,000 | $99,647 | $106,081 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Kankakee's labor market continues to diverge from state and national trends, with the metro's unemployment rate climbing to 7.0% in February 2026 before recent county-level data showed partial recovery to 4.1% in July, reflecting ongoing volatility tied to a -2.1% year-over-year contraction in total nonfarm payrolls. CSL Behring and MilliporeSigma anchor local biopharma employment even as the broader metro absorbs disruption from a $2 billion EV-battery facility build-out competing for skilled manufacturing and technical labor across the region.
What it means
Clinical Research Associate advertised pay in Kankakee has moved up significantly to a $83,763 median, narrowing the gap with the $90,956 national figure and signaling that even a smaller biopharma labor pool is pricing talent closer to national benchmarks as CSL Behring and MilliporeSigma compete for scarce clinical and quality staff. Validation Engineer pay holding stable locally at $99,647 against a moderately rising national median of $108,377 suggests Kankakee employers retain a cost advantage on engineering-adjacent roles even as regional manufacturing demand intensifies from the EV-battery project. Organizations should evaluate whether CRA compensation increases reflect durable scarcity or short-term competitive bidding before resetting base pay structures across clinical functions.
Looking ahead
Early indicator: Watch whether Kankakee County's July unemployment improvement to 4.1% holds through September reporting, given the metro posted the state's largest unemployment increase just months earlier. A reversal would suggest continued labor supply instability for CSL Behring and MilliporeSigma hiring plans.
Emerging pressure point: EV-battery facility hiring ramp toward 2,600 projected jobs may begin pulling skilled technicians and engineers away from biopharma manufacturing and quality roles that compete for similar credentialed talent pools. Monitor whether Validation Engineer and manufacturing technician postings require pay increases to stay competitive.
Worth watching: Illinois labor force contraction of 94,600 workers year-over-year through August reduces the statewide replacement pipeline for regulatory, analytical and quality roles. Kankakee employers drawing from Chicago-area or downstate talent pools should expect longer time-to-fill for credential-heavy positions.
Potential inflection point: National biopharma layoffs (BioMarin, Bristol Myers) concentrated in consolidation functions, not execution-critical roles, mean displaced talent may not flow toward Kankakee's smaller biopharma operations. Track whether local employers see any uptick in experienced regulatory or CMC applicants from national restructuring activity.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.